ID

13876

Description

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time; ODM derived from: https://clinicaltrials.gov/show/NCT01423474

Link

https://clinicaltrials.gov/show/NCT01423474

Keywords

  1. 3/13/16 3/13/16 -
Uploaded on

March 13, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostatic Neoplasms NCT01423474

Eligibility Prostatic Neoplasms NCT01423474

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
low or intermediate risk prostate cancer patients as defined by:
Description

prostate cancer

Data type

boolean

Alias
UMLS CUI [1]
C0600139
clinical stage t1-2b, gleason score <=7, and psa <=20 ng/ml
Description

tumor stage; gleason score; prostate specific antigen

Data type

boolean

Alias
UMLS CUI [1]
C1300072
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0138741
age >= 18 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
androgen deprivation therapy (lhrh-agonists or antiandrogens) >6 months
Description

Antiandrogen therapy

Data type

boolean

Alias
UMLS CUI [1]
C0279492
prior pelvic radiotherapy
Description

pelvic radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0436276
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Description

anticoagulation medication

Data type

boolean

Alias
UMLS CUI [1]
C0003280
diagnosis of bleeding diathesis
Description

bleeding diathesis

Data type

boolean

Alias
UMLS CUI [1]
C0005779
large prostate (>90cm3) on imaging
Description

large prostate

Data type

boolean

Alias
UMLS CUI [1]
C0426732
immunosuppressive medications
Description

immunosuppressive medications

Data type

boolean

Alias
UMLS CUI [1]
C0021081
inflammatory bowel disease
Description

inflammatory bowel disease

Data type

boolean

Alias
UMLS CUI [1]
C0021390

Similar models

Eligibility Prostatic Neoplasms NCT01423474

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
low or intermediate risk prostate cancer patients as defined by:
boolean
C0600139 (UMLS CUI [1])
tumor stage; gleason score; prostate specific antigen
Item
clinical stage t1-2b, gleason score <=7, and psa <=20 ng/ml
boolean
C1300072 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0138741 (UMLS CUI [3])
age
Item
age >= 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antiandrogen therapy
Item
androgen deprivation therapy (lhrh-agonists or antiandrogens) >6 months
boolean
C0279492 (UMLS CUI [1])
pelvic radiotherapy
Item
prior pelvic radiotherapy
boolean
C0436276 (UMLS CUI [1])
anticoagulation medication
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
C0003280 (UMLS CUI [1])
bleeding diathesis
Item
diagnosis of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])
large prostate
Item
large prostate (>90cm3) on imaging
boolean
C0426732 (UMLS CUI [1])
immunosuppressive medications
Item
immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])
inflammatory bowel disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial